[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
December 3, 2014

Zirconium Cyclosilicate for Treatment of Hyperkalemia

Author Affiliations
  • 1Veterans Administration Medical Center, Iowa City, Iowa
  • 2Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City
JAMA. 2014;312(21):2217-2218. doi:10.1001/jama.2014.15736

Hyperkalemia is a commonly encountered clinical problem and has been reported in up to 10% of hospitalized patients, with 10% to 38% of those episodes associated with medications that block the renin-angiotensin-aldosterone system (RAAS).1 Mortality has been shown to be increased in patients with hyperkalemia even after accounting for other comorbidities.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×